Immunosuppressants in the treatment of pemphigus.
D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007239:Infections / Q000150:complications; D008297:Male; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009092:Mucous Membrane; D010392:Pemphigus / Q000150:complications / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D012871:Skin Diseases / Q000188:drug therapy; D014221:Triamcinolone / Q000008:administration & dosage*
D014221:Triamcinolone; D001379:Azathioprine; D011241:Prednisone; D008727:Methotrexate